Sign in

CIK 0001553643

  • Non-accelerated filer
  • Smaller reporting company

RELMADA THERAPEUTICS, INC.

Sign in to watch
Ticker
RLMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
455401931
Phone
+1 646-876-3459
Business address
2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
Former names
CAMP NINE, INC.
  1. 4/A Exercise or conversion CFO acquired 4,000 shares (option exercise)
  2. 4/A Open-market sale Director sold 1,800 shares at $35.43 ($63,774)
  3. 4 Open-market sale Director sold 4,085 shares at an average $1,580.95 ($6,458,190)
  4. 4 Open-market sale CEO sold 4,070 shares at an average $35.43 ($144,180)
  5. 4 Open-market sale CFO sold 4,000 shares at an average $35.40 ($141,612)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Director sold 3,000 shares at $32.11 ($96,342)
  14. 4 Open-market sale Director sold 3,000 shares at $35.74 ($107,219)
  15. 4 Open-market sale Director sold 3,000 shares at $30.29 ($90,864)
  16. 4 Open-market sale Director sold 3,000 shares at $37.99 ($113,956)
  17. 4 Open-market sale Director sold 3,000 shares at $34.74 ($104,207)
  18. 4 Exercise or conversion Director acquired 22,000 shares (option exercise)
  19. 4 Exercise or conversion CEO acquired 50,008 shares (option exercise)
  20. 4 Shares withheld for taxes Director gave up 2,189 shares (to pay taxes)

Page 7 of 10 · 200 filings